Inventor · disambiguated record
Robert Shorr
Also filed as: SHORR ROBERT · SHORR ROBERT G L
49 granted patents·12 pending applications·1,725 citations·filing 1988–2022
99Inventor score
Files withENZON INC18RAFAEL PHARMACEUTICALS INC14SHORR ROBERT G L5CORNERSTONE PHARMACEUTICALS3CORNERSTONE PHARMACEUTICALS INC3
Top patents by PatentIndex Score
61 records- 0198US6743896B2Single-chain antigen-binding proteins capable of glycosylation, production and uses thereofENZON INC·Filed 2001·Granted Jun 1, 2004·164 cites·36 claims
- 0296US6872393B2Polyalkylene oxide-modified single chain polypeptidesENZON INC·Filed 2001·Granted Mar 29, 2005·53 cites·17 claims
- 0396US6803386B2Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancerUNITED THERAPEUTICS CORP·Filed 2002·Granted Oct 12, 2004·89 cites·16 claims
- 0496US6743908B2Single-chain antigen-binding proteins capable of glycosylation, production and uses thereofENZON INC·Filed 2001·Granted Jun 1, 2004·55 cites·67 claims
- 0596US5767260AAntigen-binding fusion proteinsENZON INC·Filed 1995·Granted Jun 16, 1998·155 cites·8 claims
- 0695US6242482B1Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failureUNITED THERAPEUTICS CORP·Filed 2000·Granted Jun 5, 2001·84 cites·51 claims
- 0793US6824782B2Polyalkylene oxide-modified single chain polypeptidesENZON INC·Filed 2001·Granted Nov 30, 2004·24 cites·13 claims
- 0893US5650388AFractionated polyalkylene oxide-conjugated hemoglobin solutionsENZON INC·Filed 1995·Granted Jul 22, 1997·109 cites·51 claims
- 0992USRE43295EPharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cellsSHORR ROBERT G L·Filed 2011·Granted Apr 3, 2012·8 cites·23 claims
- 1092US5312808AFractionation of polyalkylene oxide-conjugated hemoglobin solutionsENZON INC·Filed 1992·Granted May 17, 1994·121 cites·21 claims
- 1191US8263653B2Pharmaceutical formulations containing lipoic acid derivativesSHORR ROBERT G L·Filed 2009·Granted Sep 11, 2012·13 cites·1 claims
- 1291US7521066B2Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cellsCORNERSTONE PHARMACEUTICALS·Filed 2007·Granted Apr 21, 2009·8 cites·9 claims
- 1391US5428128ASite specific synthesis of conjugated peptidesFiled 1994·Granted Jun 27, 1995·157 cites·29 claims
- 1490US9839691B2Methods of treating pancreatic and ovarian cancers using compositions containing an ion pair of a lipoic acid derivativeCORNERSTONE PHARMACEUTICALS INC·Filed 2015·Granted Dec 12, 2017·8 cites·12 claims
- 1590US7150872B2Polyalkylene oxide-modified single chain polypeptidesENZON INC·Filed 2004·Granted Dec 19, 2006·22 cites·23 claims
- 1690US6013283AAlkyl or olefinic endcapped polyalkylene oxide solubilizerENZON INC·Filed 1997·Granted Jan 11, 2000·48 cites·11 claims
- 1788US8691873B2Pharmaceutical formulations containing lipoic acid derivativesSHORR ROBERT G L·Filed 2011·Granted Apr 8, 2014·10 cites·4 claims
- 1888US5686110AWater soluble complex of an alkyl or olefinic end capped polyalkylene oxide and a water insoluble substanceENZON INC·Filed 1995·Granted Nov 11, 1997·76 cites·9 claims
- 1988US5478805AFractionation of polyalkylene oxide-conjugated hemoglobin solutionsENZON INC·Filed 1993·Granted Dec 26, 1995·65 cites·29 claims
- 2087US9320726B2Methods of treating colon, lung, and liver cancers using compositions containing an ion pair of a lipoic acid derivativeCORNERSTONE PHARMACEUTICALS INC·Filed 2014·Granted Apr 26, 2016·8 cites·20 claims
- 2187US6323322B1Single-chain antigen-binding proteins capable of glycosylation, production and uses thereofENZON INC·Filed 1998·Granted Nov 27, 2001·37 cites·33 claims
- 2287US5153166AChromatographic stationary supportsTRUSTEES OF AT BIOCHEM·Filed 1988·Granted Oct 6, 1992·82 cites·18 claims
- 2386US10391177B2Methods for treating cancer using 6,8-bis (benzylthio) octanonic acidRAFAEL PHARMACEUTICALS INC·Filed 2018·Granted Aug 27, 2019·3 cites·44 claims
- 2485US10098955B2Pharmaceutical formulations containing lipoic acid derivativesRAFAEL PHARMACEUTICALS INC·Filed 2017·Granted Oct 16, 2018·3 cites·22 claims
- 2585US9872845B2Methods of treating myeloma and lymphoma using compositions containing an ion pair of a lipoic acid derivativeRAFAEL PHARMACEUTICALS INC·Filed 2016·Granted Jan 23, 2018·4 cites·20 claims
- 2685US7220428B2Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cellsCORNERSTONE PHARMACEUTICALS·Filed 2004·Granted May 22, 2007·14 cites·19 claims
- 2785US5264555AProcess for hemoglobin extraction and purificationENZON INC·Filed 1992·Granted Nov 23, 1993·76 cites·64 claims
- 2882US7387790B2Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cellsCORNERSTONE PHARMACEUTICALS·Filed 2002·Granted Jun 17, 2008·13 cites·13 claims
- 2980US7220538B2Composition for maintaining organ and cell viabilityLIFEBLOOD MEDICAL INC·Filed 2004·Granted May 22, 2007·20 cites·29 claims
- 3078US7632504B2Polyalkylene oxide-modified single chain polypeptidesENZON INC·Filed 2004·Granted Dec 15, 2009·9 cites·24 claims
- 3177US11622950B2Therapeutic methods and compositions for treating pancreatic cancer using 6,8-bis-benzylthio-octanoic acidRAFAEL PHARMACEUTICALS INC·Filed 2019·Granted Apr 11, 2023·2 cites·10 claims
- 3277US5705153AGlycolipid enzyme-polymer conjugatesUS ARMY·Filed 1996·Granted Jan 6, 1998·36 cites·10 claims
- 3376US11065335B2Methods of treating leukemia using compositions containing bis(benzylthio)octanoic acid and ion pairs thereofRAFAEL PHARMACEUTICALS INC·Filed 2019·Granted Jul 20, 2021·0 cites·4 claims
- 3472US5055517AElectrophoretic mediaAT BIOCHEM·Filed 1989·Granted Oct 8, 1991·37 cites·15 claims
- 3571US10179796B2Pharmaceutical compoundsRAFAEL PHARMACEUTICALS INC·Filed 2017·Granted Jan 15, 2019·1 cites·24 claims
- 3671US7537885B2Composition for maintaining organ and cell viabilityLIFEBLOOD MEDICAL INC·Filed 2007·Granted May 26, 2009·3 cites·23 claims
- 3771US5900402AMethod of reducing side effects associated with administration of oxygen-carrying proteinsENZON INC·Filed 1997·Granted May 4, 1999·35 cites·43 claims
- 3864US2020331931A1Pharmaceutical compoundsRAFAEL PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3963US5620884AGlycolipid enzyme-polymer conjugatesENZON INC·Filed 1994·Granted Apr 15, 1997·12 cites·15 claims
- 4063US2022288018A1Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndromePRE D PARTNERS LLC·Filed 2022·Application pending·0 cites
- 4162US5728560AMethod of treating CD4+ T cell lymphopenia in immuno-compromised patientsENZON INC·Filed 1996·Granted Mar 17, 1998·24 cites·18 claims
- 4262US2008262077A1Pharmaceutical formulations containing lipoic acid derivativesSHORR ROBERT G L·Filed 2008·Application pending·0 cites
- 4360US2018273551A1Pharmaceutical compoundsRAFAEL PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4459US2013150445A1Pharmaceutical Formulations Containing Lipoic Acid DerivativesSHORR ROBERT G L·Filed 2012·Application pending·0 cites
- 4557US2015322103A1Pharmaceutical compoundsCORNERSTONE PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4656US5786154AHuman phospholipase activating protein and methods for diagnosis of rheumatoid arthritisFiled 1995·Granted Jul 28, 1998·8 cites·1 claims
- 4756US2022184212A1Pharmaceutical formulations containing lipoic acid derivativesRAFAEL PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4855US11497761B2Compositions for the treatment of metastatic cancerBIODEV LLC·Filed 2020·Granted Nov 15, 2022·0 cites·6 claims
- 4955US11337960B2Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndromePRE D PARTNERS LLC·Filed 2015·Granted May 24, 2022·0 cites·4 claims
- 5055US10526357B2Pharmaceutical compoundsRAFAEL PHARMACEUTICALS INC·Filed 2018·Granted Jan 7, 2020·0 cites·18 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →